HBM Healthcare Investments AG

Key Figures 15.11.2023

Key Figures 31.10.2023

Key Figures 15.10.2023

HBM Healthcare Investments activates share buyback programme

HBM Healthcare Investments publishes Half-Year Report as at 30 September 2023 with key figures for the second quarter of the 2023/2024 financial year

Key Figures 30.09.2023

HBM Healthcare Investments publishes Net Asset Value per Share (NAV) of CHF 237.22 as at 30 September 2023

Key Figures 15.09.2023

Key Figures 31.08.2023

Key Figures 15.08.2023

Key Figures 31.07.2023

HBM Healthcare Investments publishes interim report for the quarter ended 30 June 2023 with key figures for the first three months of the 2023/2024 financial year

Key Figures 15.07.2023

Key Figures 30.06.2023

Cathay Biotech raises capital and enters into major strategic collaboration with China Merchants Group

Shareholders’ Meeting of HBM Healthcare Investments approved all proposals by the Board of Directors

Key Figures 15.06.2023

Key Figures 31.05.2023

Publication of Annual Report 2022/2023 and Invitation to the Ordinary Shareholders’ Meeting

Key Figures 15.05.2023

HBM Healthcare Investments year-end results 2022/2023

Key Figures 30.04.2023

Key Figures 15.04.2023

HBM Healthcare Investments publishes net asset value per share of CHF 254.80 as at 31 March 2023

Key Figures 31.03.2023

HBM Healthcare Investments announces the return of Dr Andreas Wicki; new investment of USD 12 million in ArriVent Biopharma

Key Figures 15.03.2023

Key Figures 28.02.2023

Key Figures 15.02.2023

Successful IPO of HBM portfolio company Mineralys Therapeutics